Unknown

Dataset Information

The positive efficacy of dexmedetomidine on the clinical outcomes of patients undergoing renal transplantation: evidence from meta-analysis.


ABSTRACT:

Introduction

Whether dexmedetomidine (DEX), an anesthetic adjuvant, can improve renal transplant outcomes is not clear.

Methods

We systematically identified clinical trials in which DEX was administered in renal transplantation (RT). On November 1, 2022, we searched The Cochrane Library, MEDLINE, EMBASE and https://www.

Clinicaltrials

gov/. The main outcomes were delayed graft function and acute rejection.

Results

A total of seven studies were included in the meta-analysis. The results showed that compared with the control, DEX significantly reduced the occurrence of delayed graft function (RR 0.76; 95% CI 0.60-0.98), short-term serum creatinine [postoperative day (POD) 2: (MD -22.82; 95% CI -42.01 - -3.64)] and blood urea nitrogen [POD 2: (MD -2.90; 95% CI -5.

SUBMITTER: Guo S 

PROVIDER: S-EPMC10756127 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature